USC Dornsife’s Peter Kuhn and John Carpten of Keck School of Medicine of USC will serve in the research effort aimed at reducing the national cancer death rate by 50% over the next 25 years. [1 min read]
A study by USC Dornsife researchers finds that the order of symptoms in the first wave of COVID-19 varied among virus strains. [2¼ min read]
USC Dornsife’s Peter Kuhn will serve as deputy director of a new virtual cancer center, funded by a grant from the Department of Defense. [1¾ min read]
The pilot study centers on a combination of 13 traditional medicinal compounds used in China early on in the coronavirus outbreak. [5 min read]
The researchers, who are based in the USC Michelson Center for Convergent Bioscience, found that gastrointestinal issues may set the novel coronavirus SARS-CoV-2 apart from other illnesses like influenza, helping doctors to diagnose it. [1½ min read]
Physicist Peter Kuhn aims to give patients the power to work with physicians to ensure the best possible treatment outcomes for their individual disease.
Cancer researcher and graduating senior Sophie Wix will pursue medical breakthroughs this fall as USC’s first Fulbright scholar to the University of Cambridge and the United Kingdom.
USC Michelson Center scientists use metal-tagged markers and a patient's blood sample, aiming for precise treatments of cancerous cells that spread to other organs.
